Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirintreated patients with coronary artery disease - Wallentin, L; Varenhorst, C; James, S (European Heart J, 2008)
et al.